37538787|t|The role of peripheral beta-amyloid in insulin resistance, insulin secretion, and prediabetes: in vitro and population-based studies.
37538787|a|Background: Previous experimental studies have shown that mice overexpressing amyloid precursor protein, in which beta-amyloid (Abeta) is overproduced, exhibit peripheral insulin resistance, pancreatic impairment, and hyperglycemia. We aimed to explore the effects of Abeta on insulin action and insulin secretion in vitro and the association of plasma Abeta with prediabetes in human. Methods: We examined the effects of Abeta40 and Abeta42 on insulin-inhibited glucose production in HepG2 cells, insulin-promoted glucose uptake in C2C12 myotubes, and insulin secretion in INS-1 cells. Furthermore, we conducted a case-control study (N = 1142) and a nested case-control study (N = 300) within the prospective Tongji-Ezhou cohort. Odds ratios (ORs) and 95% confidence intervals (CIs) for prediabetes were estimated by using conditional logistic regression analyses. Results: In the in vitro studies, Abeta40 and Abeta42 dose-dependently attenuated insulin-inhibited glucose production in HepG2 cells, insulin-promoted glucose uptake in C2C12 myotubes, and basal and glucose-stimulated insulin secretion in INS-1 cells. In the case-control study, plasma Abeta40 (adjusted OR: 2.00; 95% CI: 1.34, 3.01) and Abeta42 (adjusted OR: 1.94; 95% CI: 1.33, 2.83) were positively associated with prediabetes risk when comparing the extreme quartiles. In the nested case-control study, compared to the lowest quartile, the highest quartile of plasma Abeta40 and Abeta42 were associated with 3.51-fold (95% CI: 1.61, 7.62) and 2.75-fold (95% CI: 1.21, 6.22) greater odds of prediabetes, respectively. Conclusion: Elevated plasma Abeta40 and Abeta42 levels were associated with increased risk of prediabetes in human subjects, which may be through impairing insulin sensitivity in hepatocytes and myotubes and insulin secretion in pancreatic beta-cells.
37538787	39	57	insulin resistance	Disease	MESH:D007333
37538787	59	66	insulin	Gene	3630
37538787	82	93	prediabetes	Disease	MESH:D011236
37538787	212	237	amyloid precursor protein	Gene	11820
37538787	262	267	Abeta	Gene	11820
37538787	305	323	insulin resistance	Disease	MESH:D007333
37538787	325	346	pancreatic impairment	Disease	MESH:D010195
37538787	352	365	hyperglycemia	Disease	MESH:D006943
37538787	402	407	Abeta	Gene	351
37538787	411	418	insulin	Gene	3630
37538787	430	437	insulin	Gene	3630
37538787	487	492	Abeta	Gene	351
37538787	498	509	prediabetes	Disease	MESH:D011236
37538787	568	575	Abeta42	Gene	351
37538787	579	586	insulin	Gene	3630
37538787	597	604	glucose	Chemical	MESH:D005947
37538787	619	624	HepG2	CellLine	CVCL:0027
37538787	632	639	insulin	Gene	3630
37538787	649	656	glucose	Chemical	MESH:D005947
37538787	667	672	C2C12	CellLine	CVCL:0188
37538787	687	694	insulin	Gene	3630
37538787	708	713	INS-1	CellLine	CVCL:0352
37538787	922	933	prediabetes	Disease	MESH:D011236
37538787	1046	1053	Abeta42	Gene	351
37538787	1082	1089	insulin	Gene	3630
37538787	1100	1107	glucose	Chemical	MESH:D005947
37538787	1122	1127	HepG2	CellLine	CVCL:0027
37538787	1135	1142	insulin	Gene	3630
37538787	1152	1159	glucose	Chemical	MESH:D005947
37538787	1170	1175	C2C12	CellLine	CVCL:0188
37538787	1200	1207	glucose	Chemical	MESH:D005947
37538787	1219	1226	insulin	Gene	3630
37538787	1240	1245	INS-1	CellLine	CVCL:0352
37538787	1339	1346	Abeta42	Gene	351
37538787	1419	1430	prediabetes	Disease	MESH:D011236
37538787	1584	1591	Abeta42	Gene	351
37538787	1695	1706	prediabetes	Disease	MESH:D011236
37538787	1762	1769	Abeta42	Gene	351
37538787	1816	1827	prediabetes	Disease	MESH:D011236
37538787	1878	1885	insulin	Gene	3630
37538787	1930	1937	insulin	Gene	3630
37538787	Association	MESH:D010195	11820
37538787	Positive_Correlation	MESH:D011236	351
37538787	Positive_Correlation	MESH:D005947	3630
37538787	Association	MESH:D006943	11820
37538787	Negative_Correlation	351	3630
37538787	Negative_Correlation	MESH:D005947	351
37538787	Positive_Correlation	MESH:D007333	11820

